Thursday, January 14, 2010

Lauren has been doing very well for over a week. She has had no seizures night or day for the past 11 days. As you all know by now that we have been in this situation numerous times with starting a new drug, so we are still cautiously hopeful. This new drug does have a better "record" then other drugs for intractable epilepsy but because of the side effects is only used occasionally. We have had to get blood tests weekly because her red and white blood count have been low for the past few test.
Aplastic anemia is one of the bad side effect this is the warning we get about the drug....

WARNING

1. APLASTIC ANEMIA

THE USE OF FELBATOL® (felbamate) IS ASSOCIATED WITH A MARKED INCREASE IN THE INCIDENCE OF APLASTIC ANEMIA. ACCORDINGLY, FELBATOL® SHOULD ONLY BE USED IN PATIENTS WHOSE EPILEPSY IS SO SEVERE THAT THE RISK OF APLASTIC ANEMIA IS DEEMED ACCEPTABLE IN LIGHT OF THE BENEFITS CONFERRED BY ITS USE (SEE INDICATIONS). ORDINARILY, A PATIENT SHOULD NOT BE PLACED ON AND/OR CONTINUED ON FELBATOL® WITHOUT CONSIDERATION OF APPROPRIATE EXPERT HEMATOLOGIC CONSULTATION.

AMONG FELBATOL® TREATED PATIENTS, APLASTIC ANEMIA (PANCYTOPENIA IN THE PRESENCE OF A BONE MARROW LARGELY DEPLETED OF HEMATOPOIETIC PRECURSORS) OCCURS AT AN INCIDENCE THAT MAY BE MORE THAN A 100 FOLD GREATER THAN THAT SEEN IN THE UNTREATED POPULATION (I.E., 2 TO 5 PER MILLION PERSONS PER YEAR). THE RISK OF DEATH IN PATIENTS WITH APLASTIC ANEMIA GENERALLY VARIES AS A FUNCTION OF ITS SEVERITY AND ETIOLOGY; CURRENT ESTIMATES OF THE OVERALL CASE FATALITY RATE ARE IN THE RANGE OF 20 TO 30%, BUT RATES AS HIGH AS 70% HAVE BEEN REPORTED IN THE PAST.

THERE ARE TOO FEW FELBATOL® ASSOCIATED CASES, AND TOO LITTLE KNOWN ABOUT THEM TO PROVIDE A RELIABLE ESTIMATE OF THE SYNDROME'S INCIDENCE OR ITS CASE FATALITY RATE OR TO IDENTIFY THE FACTORS, IF ANY, THAT MIGHT CONCEIVABLY BE USED TO PREDICT WHO IS AT GREATER OR LESSER RISK.

IN MANAGING PATIENTS ON FELBATOL®, IT SHOULD BE BORNE IN MIND THAT THE CLINICAL MANIFESTATION OF APLASTIC ANEMIA MAY NOT BE SEEN UNTIL AFTER A PATIENT HAS BEEN ON FELBATOL® FOR SEVERAL MONTHS (E.G., ONSET OF APLASTIC ANEMIA AMONG FELBATOL® EXPOSED PATIENTS FOR WHOM DATA ARE AVAILABLE HAS RANGED FROM 5 TO 30 WEEKS). HOWEVER, THE INJURY TO BONE MARROW STEM CELLS THAT IS HELD TO BE ULTIMATELY RESPONSIBLE FOR THE ANEMIA MAY OCCUR WEEKS TO MONTHS EARLIER. ACCORDINGLY, PATIENTS WHO ARE DISCONTINUED FROM FELBATOL® REMAIN AT RISK FOR DEVELOPING ANEMIA FOR A VARIABLE, AND UNKNOWN, PERIOD AFTERWARDS.

IT IS NOT KNOWN WHETHER OR NOT THE RISK OF DEVELOPING APLASTIC ANEMIA CHANGES WITH DURATION OF EXPOSURE. CONSEQUENTLY, IT IS NOT SAFE TO ASSUME THAT A PATIENT WHO HAS BEEN ON FELBATOL® WITHOUT SIGNS OF HEMATOLOGIC ABNORMALITY FOR LONG PERIODS OF TIME IS WITHOUT RISK. IT IS NOT KNOWN WHETHER OR NOT THE DOSE OF FELBATOL® AFFECTS THE INCIDENCE OF APLASTIC ANEMIA.

IT IS NOT KNOWN WHETHER OR NOT CONCOMITANT USE OF ANTIEPILEPTIC DRUGS AND/OR OTHER DRUGS AFFECTS THE INCIDENCE OF APLASTIC ANEMIA.

APLASTIC ANEMIA TYPICALLY DEVELOPS WITHOUT PREMONITORY CLINICAL OR LABORATORY SIGNS, THE FULL BLOWN SYNDROME PRESENTING WITH SIGNS OF INFECTION, BLEEDING, OR ANEMIA. ACCORDINGLY, ROUTINE BLOOD TESTING CANNOT BE RELIABLY USED TO REDUCE THE INCIDENCE OF APLASTIC ANEMIA, BUT, IT WILL, IN SOME CASES, ALLOW THE DETECTION OF THE HEMATOLOGIC CHANGES BEFORE THE SYNDROME DECLARES ITSELF CLINICALLY. FELBATOL® SHOULD BE DISCONTINUED IF ANY EVIDENCE OF BONE MARROW DEPRESSION OCCURS.


So we have to get her tested again this Friday and see if her levels are still dropping. We really hope her test results look good because we will have to stop the drug if they go lower. This Friday we are going back to Primary Children's to get another dose of IVIG. We just have to go to the rapid treatment unit and stay for the 3-4 hours it takes to do infusion and not be admitted. So we are very hopeful that the combination of the IVIG and Felbatol will be what Lauren needs.

On a side note...The Charlie Foundation, which pretty much brought back the Ketogenic diet into practice throughout the world about 15 years ago, put a video together to try to earn votes for the $10,000 that the movie Extraordinary Measures is giving away to the wining charity. Many of the children in the video have Doose Syndrome (which is what Lauren has) the diet is one of the most effective treatments for that syndrome. Through the internet I felt like I have gotten to know some of these children and their families that have similar struggles. If you have a moment take time and watch the videos from the different charities, some are very touching.

Even though The Ketogenic diet didn't make Lauren seizure free it did so much to "heal" her brain. Because of the diet we were able to put her hockey helmet on the shelf, we had 6 months of no drugs, we were able to leave our house without her having 80 drop seizures a day. It pretty much allowed us to see the sparkle in Lauren's eye that had been taken away by the many drugs and daily seizures. It didn't heal her completely but the almost 2 years on the diet did so much to help her. So take a second and vote for the Charlie Foundation video. I have to admit that I voted for many of the other videos as well, so much to be grateful for!

http://extraordinarymeasuresthemovie.com/#/quilt

Tami

I am going to try to post some videos to show how well Lauren has been doing!

3 comments:

Kim said...

Good luck with everything! Keep us posted and tell Lauren that Scott says "HI!" We love you guys! Kim

Jennybell said...

That list of side effects makes ours look easy peasy! It's so sad the fine line you have to walk to keep your kid from having seizures. I hope it works for her! Can she stay on it indefinitely if it works and her blood work looks good?
Going to see Tuxhorn face to face tomorrow, I can't remember if I emailed you that! Called today and made an appt.

The Starbuck Family said...

I am so glad that she is doing so good. I hope her blood tests come back okay. The kids are excited to come see her this summer for Mitch's wedding. We love you guys!